These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9848298)

  • 1. Insulin-like growth factor-1 and insulin-like growth factor-binding protein-3 in women with premenstrual syndrome.
    Rapkin AJ; Cedars M; Morgan M; Goldman L
    Fertil Steril; 1998 Dec; 70(6):1077-80. PubMed ID: 9848298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of menopause and different combined estradiol-progestin regimens on basal and growth hormone-releasing hormone-stimulated serum growth hormone, insulin-like growth factor-1, insulin-like growth factor binding protein (IGFBP)-1, and IGFBP-3 levels.
    Cano A; Castelo-Branco C; Tarín JJ
    Fertil Steril; 1999 Feb; 71(2):261-7. PubMed ID: 9988395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of insulin-like growth factor binding protein-3 variation after follicle-stimulating hormone stimulation in women with polycystic ovary syndrome undergoing in vitro fertilization.
    Amato G; Izzo A; Tucker AT; Bellastella A
    Fertil Steril; 1999 Sep; 72(3):454-7. PubMed ID: 10519616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in serum concentrations of growth hormone, insulin, insulin-like growth factor and insulin-like growth factor-binding proteins 1 and 3 and urinary growth hormone excretion during the menstrual cycle.
    Juul A; Scheike T; Pedersen AT; Main KM; Andersson AM; Pedersen LM; Skakkebaek NE
    Hum Reprod; 1997 Oct; 12(10):2123-8. PubMed ID: 9402266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 17beta-estradiol regulation of human growth hormone (hGH), insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) axis in hypoestrogenic, hypergonadotropic women.
    Milewicz T; Krzysiek J; Sztefko K; Radowicki S; Krzyczkowska-Sendrakowska M
    Endokrynol Pol; 2005; 56(6):876-82. PubMed ID: 16821205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progesterone metabolite allopregnanolone in women with premenstrual syndrome.
    Rapkin AJ; Morgan M; Goldman L; Brann DW; Simone D; Mahesh VB
    Obstet Gynecol; 1997 Nov; 90(5):709-14. PubMed ID: 9351749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daily plasma estradiol and progesterone levels over the menstrual cycle and their relation to premenstrual symptoms.
    Redei E; Freeman EW
    Psychoneuroendocrinology; 1995; 20(3):259-67. PubMed ID: 7777654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor I and insulin-like growth factor-binding proteins in bovine serum and follicular fluid before and after the preovulatory surge of luteinizing hormone.
    Funston RN; Seidel GE; Klindt J; Roberts AJ
    Biol Reprod; 1996 Dec; 55(6):1390-6. PubMed ID: 8949898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of estradiol and exogenous insulin-like growth factor I (IGF-I) on the IGF-I axis during growth hormone inhibition and antagonism.
    Wilson ME
    J Clin Endocrinol Metab; 1998 Nov; 83(11):4013-21. PubMed ID: 9814485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the growth hormone-insulin-like growth factor I axis in developing and adult monkeys is affected by estradiol replacement and supplementation with insulin-like growth factor I.
    Wilson ME
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2018-28. PubMed ID: 9626134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome.
    Thierry van Dessel HJ; Lee PD; Faessen G; Fauser BC; Giudice LC
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3030-5. PubMed ID: 10487660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower insulin-like growth factor-1 concentrations in women with premenstrual dysphoric disorder.
    Thys-Jacobs S; McMahon D; Bilezikian JP
    Am J Obstet Gynecol; 2008 May; 198(5):506.e1-8. PubMed ID: 18199422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men.
    Münzer T; Rosen CJ; Harman SM; Pabst KM; St Clair C; Sorkin JD; Blackman MR
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E1006-13. PubMed ID: 16390864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatotropic axis and body weight in pre-menopausal and post-menopausal women: evidence for a neuroendocrine derangement, in absence of changes of insulin-like growth factor binding protein concentrations.
    Bernardi F; Petraglia F; Seppala M; Spinetti A; Bertolini S; Ferdeghini M; Genazzani AR
    Hum Reprod; 1998 Feb; 13(2):279-84. PubMed ID: 9557822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor binding protein-3 reduction in follicular fluid in spontaneous and stimulated cycles.
    Amato G; Izzo A; Tucker A; Bellastella A
    Fertil Steril; 1998 Jul; 70(1):141-4. PubMed ID: 9660436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like Growth Factor I and its binding protein 3 in sepsis.
    Papastathi C; Mavrommatis A; Mentzelopoulos S; Konstandelou E; Alevizaki M; Zakynthinos S
    Growth Horm IGF Res; 2013 Aug; 23(4):98-104. PubMed ID: 23611528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial.
    Brown CS; Ling FW; Andersen RN; Farmer RG; Arheart KL
    Obstet Gynecol; 1994 Nov; 84(5):779-86. PubMed ID: 7936512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea.
    Laughlin GA; Dominguez CE; Yen SS
    J Clin Endocrinol Metab; 1998 Jan; 83(1):25-32. PubMed ID: 9435412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women.
    Bowers CY; Granda R; Mohan S; Kuipers J; Baylink D; Veldhuis JD
    J Clin Endocrinol Metab; 2004 May; 89(5):2290-300. PubMed ID: 15126555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of insulin-like growth factor I and insulin-like growth factor-binding protein-1 and -3 in women with regular menstrual cycles.
    Wang HS; Lee JD; Soong YK
    Fertil Steril; 1995 Jun; 63(6):1204-9. PubMed ID: 7538473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.